European Union · Question · QUESTION_WRITTEN
E-9-2022-000565
Major discrepancies between EU states regarding the availability of medicines approved by the EMA
Introduced
8 February 2022
Last action
—
Status
answered
Sponsors
—
Subjects
Discovery layer
Source updated
13 April 2022
Records
Official question E-9-2022-000565 from European Union at European Parliament. Dated 8 February 2022. Status: answered.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
7 official files
Major differences between EU countries as regards the availability of EMA-approved medicines
QUESTION_WRITTEN · EN · 26 February 2022
Major differences between EU countries as regards the availability of EMA-approved medicines
QUESTION_WRITTEN · EN · 26 February 2022
Major differences between EU countries as regards the availability of EMA-approved medicines
QUESTION_WRITTEN · EN · 26 February 2022
Answer
QUESTION_WRITTEN_ANSWER · 13 April 2022
Discrepanţe majore între statele UE privind disponibilitatea medicamentelor aprobate de EMA
QUESTION_WRITTEN · RO · 26 February 2022
Discrepanţe majore între statele UE privind disponibilitatea medicamentelor aprobate de EMA
QUESTION_WRITTEN · RO · 26 February 2022
Discrepanţe majore între statele UE privind disponibilitatea medicamentelor aprobate de EMA
QUESTION_WRITTEN · RO · 26 February 2022
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.